Trademark: 90848313
Word
SIERRA ONCOLOGY
Status
Dead
Status Code
606
Status Date
Monday, March 4, 2024
Serial Number
90848313
Mark Type
4000
Filing Date
Monday, July 26, 2021
Published for Opposition
Tuesday, December 6, 2022
Abandoned Date
Monday, March 4, 2024

Trademark Owner History
SIERRA ONCOLOGY LLC - 1st New Owner After Publication
Sierra Oncology, Inc. - Owner At Publication

Classifications
5 Biological and chemical preparations for the treatment of cancer; pharmaceutical products, preparations, and compounds for the prevention and treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases and disorders; pharmaceutical preparations and substance for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical reagents; medical diagnostic reagents, assays, and test kits for testing of body fluids; cells, protein molecules, and molecular compounds in the nature of drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for medical purposes; DNA damage response assets, namely, pharmaceutical preparations for the treatment of conditions associated with DNA damage, namely cancer, for medical use but specifically excluding biological eye tissue, corneas, and other ocular or eye-related human tissue intended for subsequent tissue and organ implantation; pharmaceutical preparations for use in the prevention and treatment of dermatology, oncology, hematology and for gastroenterological disorders but specifically excluding biological eye tissue, corneas, and other ocular or eye-related human tissue intended for subsequent tissue and organ implantation
44 Medical services; medical services for the treatment of cancer; medical analysis services for the diagnosis and treatment of patients and persons; medical analysis services for the diagnosis of cancer; providing cancer screening services; providing a website via a global computer network featuring information in the fields of health and health information regarding cancer, cancer treatment, recovery and survival; medical evaluation and diagnosis of cancer; medical analysis for cancer diagnosis and prognosis based on DNA and RNA screening; medical services for the diagnosis of conditions of the human body; providing a website via a global computer network featuring information regarding the medical diagnosis and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; providing a website via a global computer network featuring information regarding the medical diagnosis and treatment of dermatology, oncology, hematology, and for gastroenterological disorders; providing medical information, consultancy and advisory services; providing links to the websites of others featuring information about the diagnosis and treatment of cancer
42 Development of pharmaceutical preparations and medicines; drug discovery services; pharmaceutical drug development services; research relating to medicines; medical research; pharmaceutical research and development services; medical research services in the field of cancer; research and development of biological and chemical preparations for the treatment of blood diseases, bone and bone marrow diseases, and cancer; research and development of pharmaceutical products, preparations and compounds for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; research and development of pharmaceutical preparations for use in dermatology, oncology, hematology, and for gastroenterological disorders; scientific research in the nature of conducting clinical trials for others; scientific research in the nature of conducting clinical trials regarding pharmaceutical preparations and drugs in the field of blood diseases, and cancers; DNA screening and analysis services for scientific research purposes
"ONCOLOGY"

Trademark Events
Mar 4, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 4, 2024
Abandonment - No Use Statement Filed
Aug 2, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 31, 2023
Sou Extension 1 Granted
Jul 31, 2023
Sou Extension 1 Filed
Jul 31, 2023
Sou Teas Extension Received
Feb 8, 2023
Automatic Update Of Assignment Of Ownership
Jan 31, 2023
Noa E-Mailed - Sou Required From Applicant
Dec 6, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 6, 2022
Published For Opposition
Nov 16, 2022
Notification Of Notice Of Publication E-Mailed
Oct 31, 2022
Approved For Pub - Principal Register
Oct 21, 2022
Teas/Email Correspondence Entered
Oct 20, 2022
Correspondence Received In Law Office
Oct 20, 2022
Teas Response To Office Action Received
Oct 12, 2022
Teas Change Of Correspondence Received
Oct 12, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 12, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 21, 2022
Notification Of Non-Final Action E-Mailed
Apr 21, 2022
Non-Final Action E-Mailed
Apr 21, 2022
Non-Final Action Written
Apr 20, 2022
Assigned To Examiner
Sep 24, 2021
New Application Office Supplied Data Entered
Jul 29, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24